Mesenchymal stem cells (MSCs) are multipotent cells that are being clinically explored as a
new therapeutic for treating a variety of immune-mediated diseases. First heralded as a …

Cell sheet technology (CST) is based on the use of thermoresponsive polymers, poly (N‐
isopropylacrylamide)(PIPAAm). The surface of PIPAAms is formulated in such a way as to …

Mesenchymal stem cells (MSCs) are non-hematopoietic stem cells with the capacity to
differentiate into tissues of both mesenchymal and non-mesenchymal origin. MSCs can …

Adipose tissue is now recognized as an accessible, abundant, and reliable site for the
isolation of adult stem cells suitable for tissue engineering and regenerative medicine …

Several experimental studies have suggested that mesenchymal stem cells may have value
for the treatment of clinical disorders, including myocardial infarction, diabetes, acute renal …

Heart diseases, including myocardial infarction (MI) and congestive heart failure (CHF),
have high mortality rates. Both MI and CHF are characterized by cardiac muscle damage …

Recent evidence shows that amniotic fluid (AF) contains multiple cell types derived from the
developing fetus, and may represent a novel source of stem cells for cell therapy. In this …

ASCs may ultimately represent a valuable therapeutic option in tissue rescue and repair
based on their ready availability, proangiogenesis and antiapoptotic factor secretion …

Background Keratoplasty is the most effective treatment for corneal blindness, but
suboptimal medical conditions and lack of qualified medical personnel and donated cornea …

Poor survival of mesenchymal stem cells (MSCs) compromised the efficacy of stem cell
therapy for myocardial infarction. The increase of exogenous reactive oxygen species (ROS) …